The predictive value of systemic inflammation response index and albumin-to-globulin ratio for prognosis in non-small cell lung cancer

Qiuping Xu, Yinyin Deng, Yuping Cai, Shaobin Yu, Mingqiang Kang, Fei He · 2026

Read The predictive value of systemic inflammation response index and albumin-to-globulin ratio for prognosis in non-small cell lung cancer by Qiuping Xu, Yinyin Deng, Yuping Cai, Shaobin Yu, Mingqiang Kang, Fei He (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13473555.txt.

Description

Qiuping Xu and five colleagues tested in 2026 whether two cheap blood markers can predict survival in non-small cell lung cancer. Inflammation shapes cancer outcomes, yet simple, low-cost prognostic tools remain valuable. The cohort included 748 consecutive Chinese patients. Relationships between markers, tumour features, and survival were examined through chi-squared tests, Cox regression, and spline models, with survival estimated by Kaplan-Meier curves.

Two markers stood out independently: the systemic inflammation response index, with a hazard ratio of 1.506, and the albumin-to-globulin ratio, with a hazard ratio of 0.749, meaning higher values of the first and lower values of the second went with worse survival. Combining them into a three-tier score separated risk sharply, with the highest-risk group facing a hazard ratio of 1.974. Predictive accuracy held steady near an area under the curve of 0.70. The authors offer the score as a convenient aid for risk stratification.

Catalog record

CREATORQiuping Xu, Yinyin Deng, Yuping Cai, Shaobin Yu, Mingqiang Kang, Fei He
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13473555

Browse the full library · About the Tower of Babel